Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Apr 21;22(4):e17089.
doi: 10.2196/17089.

Evaluating an Intervention Program Using WeChat for Patients With Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Evaluating an Intervention Program Using WeChat for Patients With Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial

Yuyu Jiang et al. J Med Internet Res. .

Abstract

Background: The application of telemedicine in home pulmonary rehabilitation interventions for the management of patients with chronic obstructive pulmonary disease (COPD) has achieved promising results.

Objective: This study aimed to develop a WeChat official account (Pulmonary Internet Explorer Rehabilitation [PeR]) based on social media. It further evaluated the effect of PeR on the quality of life, symptoms, and exercise self-efficacy of patients with COPD.

Methods: The functional modules of PeR were developed by a multidisciplinary team according to the electronic health-enhanced chronic care model (eCCM) components. A total of 106 patients were randomly selected (53 in the PeR group and 53 in the outpatient face-to-face group [FtF]). Pulmonary rehabilitation intervention was conducted for 3 months, and the outcome was observed for 3 months. The primary outcome was patient quality of life measured with the COPD assessment test (CAT). The secondary outcomes were evaluated using the modified Medical Research Council scale (mMRC), exercise self-regulatory efficacy scale (Ex-SRES), and St George's Respiratory Questionnaire (SGRQ).

Results: The intention-to-treat analysis was used in the study. A total of 94 participants completed the 6-month pulmonary rehabilitation program. No statistically significant differences were observed in CAT (F1,3=7.78, P=.001), Ex-SRES (F1,3=21.91, P<.001), and mMRC scores (F1,3=29.64, P<.001) between the two groups with the variation in time tendency. The Ex-SRES score had a significant effect on the CAT score (P=.03). The partial regression coefficient of Ex-SRES to CAT was 0.81, and Exp (B) was 2.24.

Conclusions: The telemedicine technology was effective using the eCCM combined with a behavioral intervention strategy centering on self-efficacy. Pulmonary rehabilitation at home through PeR and FtF could improve the sense of self-efficacy and quality of life and alleviate symptoms in patients with COPD.

Trial registration: Chinese Clinical Trial Registry ChiCTR1900022770; https://tinyurl.com/tmmvpq3.

Keywords: WeChat; chronic obstructive pulmonary disease; randomized controlled trial; self-efficacy; telemedicine; the eHealth enhanced chronic care model.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Functional modules of Pulmonary Internet Explorer Rehabilitation on the WeChat terminal.
Figure 2
Figure 2
Patient log-in process.
Figure 3
Figure 3
Consolidated Standards of Reporting Trials flowchart.
Figure 4
Figure 4
Chronic obstructive pulmonary disease assessment test score and its change over time.
Figure 5
Figure 5
Exercise self-regulatory efficacy scale score and its change over time.
Figure 6
Figure 6
Modified Medical Research Council scale score and its change over time.

References

    1. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. Pneumologie. 2017 Jan 23;71(01):9–14. doi: 10.1055/s-0042-121903. - DOI
    1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2163–2196. doi: 10.1016/S0140-6736(12)61729-2. http://europepmc.org/abstract/MED/23245607 - DOI - PMC - PubMed
    1. GBD 2015 Chronic Respiratory Disease Collaborators Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017 Sep;5(9):691–706. doi: 10.1016/S2213-2600(17)30293-X. https://linkinghub.elsevier.com/retrieve/pii/S2213-2600(17)30293-X - DOI - PMC - PubMed
    1. Alison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, Hill CJ, McDonald VM, Frith P, Cafarella P, Brooke M, Cameron-Tucker HL, Candy S, Cecins N, Chan AS, Dale MT, Dowman LM, Granger C, Halloran S, Jung P, Lee AL, Leung R, Matulick T, Osadnik C, Roberts M, Walsh J, Wootton S, Holland AE, Lung Foundation Australiathe Thoracic Society of AustraliaNew Zealand Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology. 2017 May;22(4):800–819. doi: 10.1111/resp.13025. - DOI - PubMed
    1. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man W, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen F, Casaburi R, Vercoulen J, Vogiatzis I, Gosselink R, Clini E, Effing T, Maltais F, van der Palen J, Troosters T, Janssen D, Collins E, Garcia-Aymerich J, Brooks D, Fahy B, Wouters E, ATS/ERS Task Force on Pulmonary Rehabilitation An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13–e64. doi: 10.1164/rccm.201309-1634ST. - DOI - PubMed

Publication types